Testing effectiveness (Phase 2)Study completedNCT01939353
What this trial is testing
Study of Flexible Doses of the Triple Reuptake Inhibitor EB-1020 Sustained Release (SR) in the Treatment of Adult Males With Attention-Deficit Hyperactivity Disorder
Who this might be right for
Adult ADHD
Otsuka Pharmaceutical Development & Commercialization, Inc. 45